Delivery Order SPE2DB24D2217-SPE2DB25FJWMD
Award Date 3/5/25
Potential Completion Date 3/6/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Glipizide-Metformin 2.5-500 mg tablets, a medication used to treat diabetes. The contract is a Firm Fixed Price, non-set-aside award with a ceiling value of $4,361.04 and a performance period ending on May 30, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,968.16, is for the delivery of Glipizide-Metformin 5-500 mg tablets over a period ending on April 15, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of Glipizide-Metformin 2.5-500 mg tablets to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $2,283.96, has a period of performance through May 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
- The Defense Logistics Agency awarded a $1,909.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Glipizide-Metformin 2.5-500 mg, a combination medication used to treat type 2 diabetes. The contract, which was competitively awarded with no set-aside designation, has an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 tablets of Metformin HCL ER 500 mg, a medication used to treat diabetes. The contract has a firm fixed price of $1,113.50 and a completion date of July 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This federal contract award, identified as SPE2DB24D2217|SPE2DB25FJWMM, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,829.55 firm fixed-price delivery order is for the supply of GLIPIZIDE-METFORMIN 2.5-500 MG 60S tablets, a medication used in the treatment of diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,358.08 Firm Fixed Price Delivery Order contract is for the supply of Metformin HCL 500 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of January 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,688.09 firm fixed price delivery order is for the supply of 4,564,042,875 tablets of Metformin HCl 1,000 mg, a pharmaceutical product used to treat diabetes. The delivery order was issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance...
- This is a $5,299.96 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pioglitazone-Metformin 15-850 60S, a medication used to manage diabetes. The contract has an ultimate completion date of December 26, 2023. AmerisourceBergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Metformin HCl 1,000 mg tablets. The firm-fixed-price delivery order, valued at $1,535.40, has a period of performance through November 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a broader $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...